About the Center

CNC

CNC is a scientific institute that fosters high-level biomedical and biotechnology research with societal impact, promotes multidisciplinary graduate training and provides specialized services to healthcare institutions and the entrepreneurial community. CNC is committed to fundamental research and to translating it into clinical and/or marketable applications

CNC integrates the Center for Innovation in Biomedicine and Biotechnology (CIBB) R&D Unit, a strategic partnership between CNC and the Coimbra Institute for Clinical and Biomedical Research (iCBR). CIBB brings together in a single hub of excellence the largest critical mass of investigators in Biomedicine and Biotechnology operating in the CENTRO region of Portugal. CIBB is an FCT-funded R&D Unit (UIDB/04539/2020) and an Associate Laboratory (LA/P/0058/2020).

CNC unites scientists from the Faculties of Medicine, Pharmacy and Sciences and Technology, the Institute for Interdisciplinary Research at the University of Coimbra, and from the Coimbra University Hospitals Center and Portuguese Institute of Oncology. It is also a founding partner of the Biotechnology Park BIOCANT. These unique partnerships have fostered basic and applied science, graduate studies, technology transfer and academic/non-academic collaboration.

CNC Milestones

1990

1992

1998

2001

2005

2005

2013

2014

2015

2018

2020

1990
Creation of CNC

1992
CNC is recognized by FCT as Associated Laboratory

1998
Ciência Viva creation - CNC is associated member

2001
PhD programme in Experimental Biology and Biomedicine creation

2005
Biocant creation

2005
Institute of Education and Citizenship creation

2013
CNC.IBILI Strategic Project

2014
Opening of the UC-Biotech Building

2015
Creation of Clinical Academic Center (CAC)

2018
CIBB Strategic Project

2020
Renewal of Associated Laboratory Statute

Vision & Mission

Responsible Research and Innovation are key to answer the contemporary scientific and societal challenges. 

At CNC we develop biomedical research in Neuroscience, Metabolism, Ageing and Biotechnology and focus on four main strategic pillars:

Research

Fundamental and applied biomedical research

Education

Training the new generation of researchers in emerging areas of contemporary biomedicine

Health

Promoting research translation to the clinic through strong partnership with clinicians

Entrepreneurship

Stimulating innovation and value creation

Social Involvement

Engaging society to foster a scientific culture and to build trust in science and scientists

Values

Excellence

Integrity

Innovation

Resilience

Cooperation

Responsability

Funding

Public

FCT, COMPETE-CCDRC (ESIF), Ciência Viva, Infarmed, European Commission, Defense Advanced Research Projects Agency (DARPA), National Institutes of Health (NIH).

Private

Bial, Bluepharma, Santa Casa da Misericórdia, Fundação Calouste Gulbenkian, Maratona da Saúde, “la Caixa” Foundation, AFM-Téléthon, Jérôme Lejeune Foundation,Laboratoire INNOTECH International – Innothera, Medical Research Council, Bayer, Novartis, Roche, European Association for the Study of Diabetes (EASD), Merck, Blade Therapeutics, Wave Life Sciences, Alzheimer's Foundation of America, Brain & Behaviour Research Foundation, National Ataxia Foundation, The Michael J. Fox Foundation, Progeria Research Foundation, Teva Pharmaceutical, BioBlast Pharma, Mizutani Foundation for Glycoscience.

We use cookies to improve your visit to our website.